Skip to main content
OpenTrials

Clinical trial condition

Age-Related Macular Degeneration

Explore clinical trials studying Age-Related Macular Degeneration. Study availability and eligibility vary by location and protocol.

286 public trials 39 recruiting studies
Refine in advanced search Browse all conditions

Age-Related Macular Degeneration trial results

Active, Not Recruiting

Safety and Efficacy Study of OpRegen for Treatment of Advanced Dry-Form Age-Related Macular Degeneration

NCT02286089

Conditions
Age-Related Macular Degeneration, Eye Diseases, Macular Degeneration, +2 more
Locations
  • West Coast Retina Medical Group San Francisco, California, United States
  • Cincinnati Eye Institute Cincinnati, Ohio, United States
  • Mid Atlantic Retina Philadelphia, Pennsylvania, United States
  • Hadassah Medical Center Jerusalem, Israel
View Trial Details
Active, Not Recruiting

A Study About the Safety of ASP3021 Eye Injections and if They Help People in Japan With Vision Loss From Age-related Macular Degeneration

NCT06970665

Conditions
Age-Related Macular Degeneration, Eye Diseases, Geographic Atrophy, +3 more
Locations
  • Nagoya City University Hospital Nagoya, Aichi-ken, Japan
  • Fukushima Medical University Hospital Fukushima, Japan
  • Kagawa University Hospital Kita-gun, Kagawa-ken, Japan
  • Yokohama City University Medical Center Yokohama, Kanagawa, Japan
View all 16 locations
View Trial Details
Active, Not Recruiting

An Observational Study of the Progression of Intermediate Age-Related Macular Degeneration

NCT05300724

Conditions
Age-Related Macular Degeneration, Eye Diseases, Macular Degeneration, +2 more
Locations
  • Retina Partners of Northwest Arkansas, PLLC Springdale, Arkansas, United States
  • The Retina Partners Encino, California, United States
  • Retina Consultants of Orange County Fullerton, California, United States
  • Northern California Retina Vitreous Associates Mountain View, California, United States
View all 74 locations
View Trial Details
Active, Not Recruiting

A Study to Investigate Safety, Tolerability, Pharmacokinetics (PK), Pharmacodynamics (PD), and Immunogenicity of RO7669330 in Participants With Geographic Atrophy (GA) Secondary to Age-related Macular Degeneration (AMD)

NCT06961370

Conditions
Age-Related Macular Degeneration, Eye Diseases, Geographic Atrophy, +3 more
Locations
  • Associated Retina Consultants - Phoenix - DocTrials - PPDS Phoenix, Arizona, United States
  • Barnet Dulaney Perkins Eye Center Sun City, Arizona, United States
  • Retina-Vitreous Associates Medical Group Beverly Hills, California, United States
  • Global Research Management Glendale, California, United States
View all 16 locations
View Trial Details
Active, Not Recruiting

NG101 AAV Gene Therapy in Subjects With Wet Age-Related Macular Degeneration

NCT05984927

Conditions
Age-Related Macular Degeneration, Choroid Diseases, Choroidal Neovascularization, +11 more
Locations
  • Cincinnati Eye Institute Cincinnati, Ohio, United States
  • Retina Consultants of Texas Bellaire, Texas, United States
  • Vancouver Coastal Health Research Institute Vancouver, British Columbia, Canada
  • Sunnybrook Ophthalmology and Vision Services Toronto, Ontario, Canada
View Trial Details
Active, Not Recruiting

A Phase I, Open-label, Multicenter, Dose-Escalating Study to Evaluate the Safety and Tolerability of KH658 Gene Therapy in Participants With Neovascular Age-related Macular Degeneration

NCT06825858

Conditions
Age-Related Macular Degeneration, Eye Diseases, Macular Degeneration, +2 more
Locations
  • Kanghong Investigative Site Phoenix, Arizona, United States
  • Kanghong Investigative Site Lemont, Illinois, United States
  • Kanghong Investigative Site Memphis, Tennessee, United States
View Trial Details
Active, Not Recruiting

Safety and Tolerability of KH631 Gene Therapy in Participants With Neovascular Age-related Macular Degeneration

NCT05657301

Conditions
Age-Related Macular Degeneration, Eye Diseases, Macular Degeneration, +2 more
Locations
  • Kanghong Investigative Site Phoenix, Arizona, United States
  • Kanghong Investigative Site Lemont, Illinois, United States
  • Kanghong Investigative Site Boston, Massachusetts, United States
  • Kanghong Investigative Site Reno, Nevada, United States
View Trial Details

Related conditions